Development and validation of a GC method for a key nemtabrutinib intermediate: Implementation of an in-situ free base sample preparation protocol
A novel synthetic approach to nemtabrutinib (MK-1026) was recently developed in our laboratories. The chemistry goes through a cyrene amine intermediate which does not contain any chromophore. As a result, analysis of this key chiral intermediate by HPLC-UV is not feasible. Initial attempts to devel...
Saved in:
Published in | Journal of pharmaceutical and biomedical analysis Vol. 241; p. 116002 |
---|---|
Main Authors | , , , , |
Format | Journal Article |
Language | English |
Published |
England
Elsevier B.V
15.04.2024
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Be the first to leave a comment!